OBI Pharma Enters Exclusive Agreement with MSD for Rights to DIFICID® (fidaxomicin) in Taiwan
UPDATE: 5 reasons to double-down and buy stocks today
Pivotal Phase 3 Studies of Bezlotoxumab, Merck’s Investigational Antitoxin to Prevent Clostridium Difficile Infection Recurrence, Met Primary Endpoint
UPDATE: Why Democrats look set to keep the White House in 2016 presidential election
Ritter Pharmaceuticals to Present at the 3rd Microbiome R&D Business Collaboration Forum
UPDATE: America, like Coke, sweetens on Stevia
Utilities' 4% dividend yields still look attractive even with the chance for rising interest rates.
Existing- and new home sales were both better than expected, and durable goods orders, ex-transportation, were up.